A revolutionary tool to find new therapeutic avenues The innovative project based on iPS cells proposed by Delphine Bohl was selected in 2010 Project. Her very interesting results have been recently published, she comments them for the Foundation Human induced...
The emerging understanding of the role of G-quadruplexes in neurodegenerative diseases raises new possibilities for therapeutic intervention The research project led by Pr Adrian Isaacs, Department of Neurodegenerative Disease, Institute of Neurology at UC, was selected in 2013. During...
The discovery of a prognostic biomarker in ALS Within the prestigious University of Oxford (ranked for 2014-2015 as number one University in Health Science by the Times Magazine), Dr. Martin Turner undertakes a cutting- edge research on biomarkers. ...
An important result: The ANGIOGENIN project opens the way to a pharmaceutical development of a new treatment. The only objective of the Thierry Latran Foundation is to accelerate research to find a treatment. The selected projects must of...
A very good news for patient Masitinib Receives Orphan Drug Designation for Amyotrophic Lateral Sclerosis from FDA
Identification of pathways of degeneration and protection in ALS using oculomotor neuron resistance as a tool. Eva Hedlund, associate professor in the department of Neuroscience at Karolinska Institute in Sweden and Stefania Corti associate professor in the Neurology unit...
Following the project selected in 2009 by the Thierry Latran Foundation : Study of the pathological neuro-immune interactions between the macrophages/microglial cells and the affected motor neurons in animal models of ALS ( PI Séverine Boillée, Sorbonne Universités, UPMC...
Results making a significant contribution to understand the mechanisms of ALS neurodegeneration, and may providing insights to identify new targets for possible therapeutic manipulations Following the project selected in 2011 by the Thierry Latran Foundation : What is the...
ALS generally appears between the ages of 40 and 70, but can also affect adults older or younger and, in rare cases, adolescents. Compared to other neurodegenerative diseases, the number of victims at a given moment in a given...
6th Call for Projects: 2 New Selected Projects The sixth call for projects opened in November 2013 to finance research with potential therapeutic benefit in sporadic ALS on the following themes: Biological markers, pathological pathways and mechanisms, therapeutic strategies,...